Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing.
Cheung CC, Lim HJ, Garratt J, Won J, Gilks CB, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):251-257. doi: 10.1097/PAI.0000000000000734. Appl Immunohistochem Mol Morphol. 2019. PMID: 30789848 Clinical Trial.
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
Terry J, Torlakovic EE, Garratt J, Miller D, Köbel M, Cooper J, Bahzad S, Pilavdzic D, O'Malley F, O'Brien AE, SenGupta S, Alport E, Têtu B, Knight B, Pettigrew NM, Berendt R, Wolber R, Trotter MJ, Riddell RH, Gaboury L, Elms F, Magliocco A, Barnes P, Gown AM, Gilks CB. Terry J, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):375-82. doi: 10.1097/PAI.0b013e31819adacf. Appl Immunohistochem Mol Morphol. 2009. PMID: 19363444
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M; International Ad Hoc Expert Panel. Torlakovic EE, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52. doi: 10.1097/PAI.0000000000000069. Appl Immunohistochem Mol Morphol. 2014. PMID: 24714041 Free PMC article.
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
Torlakovic EE, Nielsen S, Francis G, Garratt J, Gilks B, Goldsmith JD, Hornick JL, Hyjek E, Ibrahim M, Miller K, Petcu E, Swanson PE, Zhou X, Taylor CR, Vyberg M. Torlakovic EE, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):1-18. doi: 10.1097/PAI.0000000000000163. Appl Immunohistochem Mol Morphol. 2015. PMID: 25474126 Review.
Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.
Cheung CC, Garratt J, Won J, Cutz JC, Gilks BC, Tsao M, Torlakovic EE. Cheung CC, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):677-81. doi: 10.1097/PAI.0000000000000267. Appl Immunohistochem Mol Morphol. 2015. PMID: 26551338 Clinical Trial.
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP).
Cheung CC, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F, Couture C, Deschenes J, El-Zimaity H, Fischer G, Fiset PO, Garratt J, Geldenhuys L, Gilks CB, Ilie M, Ionescu D, Lim HJ, Manning L, Mansoor A, Riddell R, Ross C, Roy-Chowdhuri S, Spatz A, Swanson PE, Tron VA, Tsao MS, Wang H, Xu Z, Torlakovic EE; Canadian Association of Pathologists-Association Canadienne Des Pathologistes’ National Standards Committee for High Complexity Testing (CAP-ACP NSCHCT). Cheung CC, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2019 Nov/Dec;27(10):699-714. doi: 10.1097/PAI.0000000000000800. Appl Immunohistochem Mol Morphol. 2019. PMID: 31584451 Free PMC article.
Canadian external quality assurance program for breast cancer biomarkers.
Terry J, Torlakovic E, Trotter M, Garratt J, Barnes P, Gown A, Pettigrew N, Gilks CB. Terry J, et al. Among authors: garratt j. Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):486. doi: 10.1097/PAI.0b013e3181e2de01. Appl Immunohistochem Mol Morphol. 2010. PMID: 20502320 No abstract available.
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experience.
Copete M, Garratt J, Gilks B, Pilavdzic D, Berendt R, Bigras G, Mitchell S, Lining LA, Cheung C, Torlakovic EE. Copete M, et al. Among authors: garratt j. J Clin Pathol. 2011 Mar;64(3):220-5. doi: 10.1136/jcp.2010.085258. Epub 2011 Jan 22. J Clin Pathol. 2011. PMID: 21258091
53 results